cysteine and Heritable Pulmonary Arterial Hypertension

cysteine has been researched along with Heritable Pulmonary Arterial Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P1
Ali, MK; Andruska, A; Spiekerkoetter, E1
Chan, SY; Handy, DE; Leopold, JA; Loscalzo, J; Mahoney, CE; Maron, BA; White, K; Zhang, YY1

Other Studies

3 other study(ies) available for cysteine and Heritable Pulmonary Arterial Hypertension

ArticleYear
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
    European journal of pharmacology, 2022, Oct-15, Volume: 933

    Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling

2022
Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension.
    American journal of respiratory cell and molecular biology, 2020, Volume: 63, Issue:2

    Topics: Bone Morphogenetic Protein Receptors, Type II; Cysteine; Familial Primary Pulmonary Hypertension; Humans; Precision Medicine; Pulmonary Arterial Hypertension

2020
Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.
    Circulation, 2012, Aug-21, Volume: 126, Issue:8

    Topics: Aldosterone; Animals; Cells, Cultured; Cysteine; Disease Models, Animal; Endothelial Cells; Endothelin-1; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Pulmonary Artery; Pulmonary Wedge Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Spironolactone; Sulfhydryl Compounds

2012